Consejo Nacional de Salud

552
14 Samudre SS, Lattanzio FA Jr, Williams PB, Sheppard
JD Jr., Comparison of topical steroids for
acute anterior uveitis, J Ocul Pharmacol Ther.
2004 Dec;20(6):533-47.´
15 Wu KY, Wang HZ, Hong SJ., Effects of antibiotics
and corticosteroid eyedrops on cellular proliferation
in cultured human corneal keratocytes, Kaohsiung
J Med Sci. 2006 Aug;22(8):385-9
16 Yang CQ, Sun W, Gu YS, A clinical study of the
efficacy of topical corticosteroids on dry eye, J
Zhejiang Univ Sci B. 2006 Aug;7(8):675-8.
17 Samudre SS, Lattanzio FA Jr, Williams PB, Sheppard
JD Jr., Comparison of topical steroids for
acute anterior uveitis, J Ocul Pharmacol Ther.
2004 Dec;20(6):533-47.´
18 Bartlett JD, Holland EJ, Usner DW, Paterno
MR, Comstock TL, Tolerability of loteprednol/
tobramycin versus dexamethasone/tobramycin in
healthy volunteers: results of a 4-week, randomized,
double-masked, parallel-group study, Curr
Med Res Opin. 2008 Aug;24(8):2219-27. Epub
2008 Jun 23.
19 McCormick C, Caballero A, Tang A, Balzli C,
Song J, O'Callaghan R., Effectiveness of a new
tobramycin (0.3%) and dexamethasone (0.05%)
formulation in the treatment of experimental
Pseudomonas keratitis, Curr Med Res Opin. 2008
Jun;24(6):1569-75. Epub 2008 Apr 17
20 Shimazaki A., Basis of anti-glaucoma agents, Nippon
Yakurigaku Zasshi. 2006 Oct;128(4):250-4
21 Aggarwal D, Pal D, Mitra AK, Kaur IP., Study of the
extent of ocular absorption of acetazolamide from
a developed niosomal formulation, by microdialysis
sampling of aqueous humor, Int J Pharm. 2007 Jun
29;338(1-2):21-6. Epub 2007 Jan 19
22 Mincione F, Scozzafava A, Supuran CT, The development
of topically acting carbonic anhydrase
inhibitors as antiglaucoma agents. Curr Pharm
Des. 2008;14(7):649-54
23 Plant T, Aref-Adib G, Travelling to new heights:
practical high altitude medicine, Br J Hosp Med
(Lond). 2008 Jun;69(6):348-52
24 Rivera-Ch M, Huicho L, Bouchet P, Richalet JP,
León-Velarde F, Effect of acetazolamide on ventilatory
response in subjects with chronic mountain
sickness, Respir Physiol Neurobiol. 2008 Aug
31;162(3):184-9. Epub 2008 Jun 17
25 Lyall DA., Unexpected control of a patient's
refractory epilepsy when treating glaucoma
with acetazolamide, Can J Ophthalmol. 2008
Jun;43(3):377
26 Vold SD, Evans RM, Stewart RH, Walters T,
Mallick S., A one-week comfort study of BIDdosed
brinzolamide 1%/timolol 0.5% ophthalmic
suspension fixed combination compared to BIDdosed
dorzolamide 2%/timolol 0.5% ophthalmic
solution in patients with open-angle glaucoma
or ocular hypertension., J Ocul Pharmacol Ther.
2008 Dec;24(6):601-5.
27 Minello AA, Prata Junior JA, Mello PA, Efficacy
of topic ocular hipotensive agents after posterior
capsulotomy, Arq Bras Oftalmol. 2008 Sep-
Oct;71(5):706-10. Portuguese., PMID: 19039468
[PubMed - in process]
28 Torring MS, Holmgaard K, Hessellund A, Aalkjaer
C, Bek T, The vasodilating effect of acetazolamide
and dorzolamide involves other mechanisms than
carbonic anhydrase inhibition, Invest Ophthalmol
Vis Sci. 2008 Aug 29., PMID: 18757514 [PubMed
- as supplied by publisher]